相关实验视频

Updated: Jul 9, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

针对IL-2/CD25结合抑制的塞拉斯托尔诱导T细胞介导的抗瘤活性在黑色素瘤中

Okki Cho¹, Joong-Woon Lee¹, Young-Jin Jeong¹

¹Laboratory of Pharmacoimmunology, Integrated Research Institute of Pharmaceutical Sciences and BK21 FOUR Team for Advanced Program for SmartPharma Leaders, College of Pharmacy, The Catholic University of Korea, 43 Jibong-ro, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

European journal of pharmacology

|December 3, 2023

概括

塞拉斯 (CEL) 通过直接向IL-2来抑制INTERLEUKIN-2 (IL-2) 信号传递,通过增强CD8+T细胞来增强对黑色素瘤的抗瘤活性. 与CEL和TNFR2抗剂的联合治疗显示出协同效应.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
药理学药理学是指药理学的学科.

背景情况:

介素-2 (IL-2) 信号传递对免疫反应至关重要,但其选择性向仍然是癌症治疗中的挑战.
塞拉斯 (CEL) 被确定为IL-2/CD25结合的抑制剂,促使对其治疗潜力的研究.

研究的目的:

为了研究IL-2的抑制作用和CEL的抗瘤活性.
阐明CEL在免疫细胞中的作用及其在癌症免疫治疗中的作用机制.

主要方法:

评估了CEL与IL-2和CD25的结合.
在实验室中评估了CEL对依赖IL-2的T细胞增殖,信号和STAT5酸化的影响.
在小鼠黑色素瘤模型 (C57BL/6和T细胞缺乏BALB/c裸体小鼠) 中测试了CEL的抗瘤活性.
研究了使用CEL和TNFR2抗剂的组合疗法.

主要成果:

CEL直接与IL-2结合,影响IL-2/CD25结合,抑制T细胞的增殖和信号传递.
通过增加CD8+T细胞,CEL在C57BL/6小鼠中显示出显著的抗瘤活性,其活性取决于T细胞.
组合疗法通过增加内CD8/Treg比率和抑制Foxp3.3来协同增强治疗疗效.

结论:

通过准IL-2,CEL抑制IL-2的作用,通过T细胞介导反应产生抗瘤作用.
CEL是癌症免疫治疗的有希望的候选者,特别是在黑色素瘤的联合治疗中.

关键词:

癌症免疫疗法癌症免疫疗法塞拉斯特罗尔 (celastrol) 是一种组合疗法是一种联合疗法.介质蛋白-2 介质蛋白-2 的作用.自然的小分子.这就是TNFR2的特点.

更多相关视频

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...